glp 1 agonist mechanism of action weight loss Mechanisms of GLP-1RA Frontiers | GLP−1 receptor agonists
Description
Which differentiating factors will enable specific companies and drugs to capture this market (and potentially $100B in upside)
In a study (New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes) published on February 12, 2026, participants who started taking semaglutide were about 2 times more likely to develop NAION than participants who took sodium-glucose cotransporter-2 inhibitors
Beyond its proven ability to help with weight loss, growing research is uncovering GLP-1 drugs potential to address a range of other health conditions
Findings from a large multicenter analysis of more than 1.5 million adults with type 2 diabetes in six national health databases were in line with these results
How Does GLP-1 Work
